MX2020008086A - Metodos y composiciones para tratar la apnea del sue?o. - Google Patents
Metodos y composiciones para tratar la apnea del sue?o.Info
- Publication number
- MX2020008086A MX2020008086A MX2020008086A MX2020008086A MX2020008086A MX 2020008086 A MX2020008086 A MX 2020008086A MX 2020008086 A MX2020008086 A MX 2020008086A MX 2020008086 A MX2020008086 A MX 2020008086A MX 2020008086 A MX2020008086 A MX 2020008086A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- sleep apnea
- compositions
- treating sleep
- nri
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
En general, la invención se refiere a composiciones farmacéuticas que comprenden (R)-oxibutinina y un inhibidor de la recaptación de la norepinefrina (IRN), y a métodos para tratar la apnea del sueño que comprenden administrar (R)-oxibutinina y un inhibidor de la recaptación de la norepinefrina (IRN). En algunas realizaciones, el IRN es atomoxetina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862623892P | 2018-01-30 | 2018-01-30 | |
PCT/US2019/015781 WO2019152475A1 (en) | 2018-01-30 | 2019-01-30 | Methods and compositions for treating sleep apnea |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020008086A true MX2020008086A (es) | 2021-02-15 |
Family
ID=65441079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020008086A MX2020008086A (es) | 2018-01-30 | 2019-01-30 | Metodos y composiciones para tratar la apnea del sue?o. |
Country Status (14)
Country | Link |
---|---|
US (2) | US11911351B2 (es) |
EP (1) | EP3746126A1 (es) |
JP (2) | JP7422666B2 (es) |
KR (1) | KR20200115598A (es) |
CN (1) | CN111670050A (es) |
AU (1) | AU2019214891A1 (es) |
BR (1) | BR112020015316A2 (es) |
CA (1) | CA3089712A1 (es) |
EA (1) | EA202091597A1 (es) |
IL (1) | IL276247A (es) |
MA (1) | MA52861A (es) |
MX (1) | MX2020008086A (es) |
SG (1) | SG11202007226UA (es) |
WO (1) | WO2019152475A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240042261A (ko) * | 2017-04-28 | 2024-04-01 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 수면 무호흡을 치료하기 위한 방법 및 조성물 |
US20220362221A1 (en) * | 2019-11-04 | 2022-11-17 | Apnimed, Inc. (Delaware) | Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea |
JP2024508498A (ja) * | 2021-03-04 | 2024-02-27 | アプニメッド,インコーポレイテッド(デラウェア) | 睡眠時無呼吸の治療における使用のためのレボキセチン及びムスカリン受容体拮抗薬(mra)の組み合わせ |
WO2022204228A1 (en) * | 2021-03-24 | 2022-09-29 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea |
KR20240004600A (ko) | 2021-05-04 | 2024-01-11 | 애프니메드, 인코포레이티드 (델라웨어) | (r)-옥시부티닌 d-말레이트의 고체 형태 |
BR112023026158A2 (pt) * | 2021-06-17 | 2024-03-05 | Apnimed Inc Delaware | Inibidores da recaptação de norepinefrina para tratamento da apneia do sono |
TW202342033A (zh) | 2021-12-22 | 2023-11-01 | 德商拜耳廠股份有限公司 | 用於治療睡眠呼吸中止之α2-腎上腺素受體亞型C(α-2C)拮抗劑與正腎上腺素再吸收抑制劑之組合 |
TW202342011A (zh) | 2021-12-22 | 2023-11-01 | 德商拜耳廠股份有限公司 | 用於治療睡眠呼吸中止之α2-腎上腺素受體亞型C(α-2C)拮抗劑與蕈毒鹼受體拮抗劑之組合 |
WO2023219991A1 (en) * | 2022-05-13 | 2023-11-16 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL267508A (es) | 1960-07-26 | |||
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
AU714270B2 (en) | 1995-10-24 | 1999-12-23 | Gruenenthal Gmbh | Method of inhibiting sleep apnea |
CN1396829A (zh) * | 2000-02-24 | 2003-02-12 | 法玛西雅厄普约翰美国公司 | 新的药物联合形式 |
WO2002089843A1 (en) | 2001-03-13 | 2002-11-14 | Millenium Pharmaceuticals, Inc. | Methods for treating or preventing cardiovascular disorders by modulating metalloprotease function |
US20030060513A1 (en) | 2001-09-27 | 2003-03-27 | Arneric Stephen P. | Pharmaceutical composition |
US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
US20040235925A1 (en) | 2002-12-17 | 2004-11-25 | Pharmacia Corporation | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof |
US20050009862A1 (en) | 2003-04-25 | 2005-01-13 | Sabounjian Luann | Method for promoting uninterrupted sleep by administration of trospium chloride |
ATE426405T1 (de) | 2003-12-22 | 2009-04-15 | Acadia Pharm Inc | Amino-substituierte diarylaa,ducyclohepten- analoga als muscarinische agonisten und verfahren zur behandlung von neuropsychiatrischen erkrankungen |
US20060039866A1 (en) | 2004-08-20 | 2006-02-23 | Cypress Bioscience, Inc. | Method for treating sleep-related breathing disorders |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
WO2006055854A2 (en) | 2004-11-17 | 2006-05-26 | Cypress Bioscience, Inc. | Methods for reducing the side effects associated with mirtazapine treatment |
EP1833467B1 (en) | 2004-12-20 | 2016-08-03 | Collegium Pharmaceutical, Inc. | Pharmaceutical compositions for sleep disorders |
CA2646729A1 (en) | 2005-03-21 | 2006-09-28 | Dov Pharmaceutical, Inc. | Methods and compositions for the treatment of urinary incontinence |
EP1868602A1 (en) | 2005-04-15 | 2007-12-26 | The Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
US8364407B2 (en) | 2005-07-21 | 2013-01-29 | The Invention Science Fund I, Llc | Selective resonance of chemical structures |
FR2889811B1 (fr) | 2005-08-19 | 2009-10-09 | Sanofi Aventis Sa | Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique. |
WO2008066750A1 (en) | 2006-11-22 | 2008-06-05 | Seaside Therapeutics, Llc | Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism |
WO2008122019A1 (en) | 2007-04-02 | 2008-10-09 | Cypress Biosciences, Inc. | Improving the tolerability of both mirtazapine and reboxetine by using them in combination |
NZ580250A (en) | 2007-04-09 | 2012-05-25 | Sunovion Pharmaceuticals Inc | Methods and compositions comprising desmethylvenlafaxine or duloxetine for treating sleep-related breathing disorders |
US8415390B2 (en) | 2008-05-30 | 2013-04-09 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
US9119777B2 (en) | 2008-05-30 | 2015-09-01 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
US20090048233A1 (en) | 2007-08-16 | 2009-02-19 | Cypress Biosciences, Inc. | Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination |
BRPI0821761A2 (pt) | 2007-12-21 | 2015-06-16 | Eurand Inc | Composições de comprimidos de desintegração oral de temazepam |
US20100204058A1 (en) | 2009-01-28 | 2010-08-12 | Howard Yuan-Hao Chang | Profiling for Determination of Response to Treatment for Inflammatory Disease |
MX2012011395A (es) | 2010-04-01 | 2013-02-26 | Theravida Inc | Metodos de mejoramiento de la calidad del sueño. |
EP2672972B1 (en) | 2011-01-28 | 2020-11-04 | Pfantastic Medical Research Institute, LLC | Methods for treating obstructive sleep apnea |
JP2012176958A (ja) | 2012-04-20 | 2012-09-13 | Watson Pharmaceuticals Inc | (r)−オキシブチニンおよび(r)−デスエチルオキシブチニンによる平滑筋機能亢進の処置 |
CA2904310C (en) | 2013-03-05 | 2022-07-12 | Requis Pharmaceuticals Inc. | Preparations for the treatment of sleep-related respiratory disorders |
AU2015335375B2 (en) | 2014-10-24 | 2020-09-10 | Launx Biomedical Co., Ltd. | Use of azelnidipine in preparing medicinal composition for treating cancers |
HUE047169T2 (hu) | 2015-04-27 | 2020-04-28 | Arena Pharm Inc | 5-HT2C receptor agonisták és készítmények és felhasználási eljárások |
WO2017015309A1 (en) | 2015-07-22 | 2017-01-26 | John Hsu | Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof |
US20180235934A1 (en) | 2015-08-18 | 2018-08-23 | Massachusetts Institute Of Technology | Noradrenergic drug treatment of obstructive sleep apnea |
KR20240042261A (ko) * | 2017-04-28 | 2024-04-01 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 수면 무호흡을 치료하기 위한 방법 및 조성물 |
CN111818946A (zh) | 2018-01-31 | 2020-10-23 | 国家儿童医院研究所 | 2c型肢带型肌营养不良的基因疗法 |
SG11202108225QA (en) | 2019-02-08 | 2021-08-30 | Brigham & Womens Hospital Inc | Methods and compositions for treating sleep apnea |
-
2019
- 2019-01-30 BR BR112020015316-8A patent/BR112020015316A2/pt unknown
- 2019-01-30 EP EP19705634.4A patent/EP3746126A1/en active Pending
- 2019-01-30 WO PCT/US2019/015781 patent/WO2019152475A1/en unknown
- 2019-01-30 EA EA202091597A patent/EA202091597A1/ru unknown
- 2019-01-30 AU AU2019214891A patent/AU2019214891A1/en active Pending
- 2019-01-30 KR KR1020207024790A patent/KR20200115598A/ko unknown
- 2019-01-30 MA MA052861A patent/MA52861A/fr unknown
- 2019-01-30 MX MX2020008086A patent/MX2020008086A/es unknown
- 2019-01-30 US US16/965,960 patent/US11911351B2/en active Active
- 2019-01-30 CN CN201980010884.XA patent/CN111670050A/zh active Pending
- 2019-01-30 JP JP2020542075A patent/JP7422666B2/ja active Active
- 2019-01-30 CA CA3089712A patent/CA3089712A1/en active Pending
- 2019-01-30 SG SG11202007226UA patent/SG11202007226UA/en unknown
-
2020
- 2020-07-23 IL IL276247A patent/IL276247A/en unknown
-
2022
- 2022-08-05 US US17/882,318 patent/US20220378724A1/en not_active Abandoned
-
2023
- 2023-10-25 JP JP2023183525A patent/JP2023181322A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US11911351B2 (en) | 2024-02-27 |
US20210038541A1 (en) | 2021-02-11 |
US20220378724A1 (en) | 2022-12-01 |
JP2021516218A (ja) | 2021-07-01 |
IL276247A (en) | 2020-09-30 |
CA3089712A1 (en) | 2019-08-08 |
MA52861A (fr) | 2021-05-05 |
KR20200115598A (ko) | 2020-10-07 |
SG11202007226UA (en) | 2020-08-28 |
WO2019152475A1 (en) | 2019-08-08 |
JP2023181322A (ja) | 2023-12-21 |
EA202091597A1 (ru) | 2020-10-22 |
JP7422666B2 (ja) | 2024-01-26 |
CN111670050A (zh) | 2020-09-15 |
EP3746126A1 (en) | 2020-12-09 |
BR112020015316A2 (pt) | 2020-12-08 |
AU2019214891A1 (en) | 2020-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020008086A (es) | Metodos y composiciones para tratar la apnea del sue?o. | |
NZ758564A (en) | Methods and compositions for treating sleep apnea | |
MX2021006421A (es) | Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17). | |
NZ734516A (en) | Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n’-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine | |
MX2015012760A (es) | Composicion farmaceutica que comprende un activador de ampk y un agente serotonergico y metodos de uso de la misma. | |
MX2022013612A (es) | Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para el tratamiento de malignidades hematologicas. | |
EA201990424A1 (ru) | Спиролактамовые модуляторы nmda-рецептора и их применение | |
WO2018234568A3 (en) | HYDROXYNORKETAMINE FOR USE IN TREATING DEPRESSION | |
EA201990428A1 (ru) | Спиролактамовые модуляторы nmda-рецептора и их применение | |
MX354858B (es) | Nueva forma de administracion de inhibidor de encefalinasa. | |
PH12016501096A1 (en) | SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS | |
MX2022002196A (es) | Composición de liberación retardada de niclosamida y uso antiviral de la misma. | |
MX2022007113A (es) | Inhibidores de la desmetilasa de la histona especifica de la lisina para el tratamiento de las neoplasias mieloproliferativas. | |
MX2022015629A (es) | Uso de vibegron para tratar vejiga sobreactiva. | |
MX2022005813A (es) | Formas de dosificacion novedosas de rofecoxib y métodos relacionados. | |
MX2023000187A (es) | Dosificacion de vibegron para el tratamiento de vejiga sobreactiva. | |
EA201892098A1 (ru) | Соединение, обладающее ингибирующей мутантную idh активностью, способ его получения и применения | |
CL2023002824A1 (es) | Métodos y composiciones para tratar la apnea del sueño | |
GR1008228B (el) | Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου | |
AU2018258588A8 (en) | Inhibitors of TRIM33 and methods of use | |
IN2013MU03428A (es) | ||
MX2021008887A (es) | Minociclina para el tratamiento del sindrome de pitt-hopkins. | |
IL309251A (en) | Norepinephrine reuptake inhibitors for the treatment of sleep apnea | |
IN2013MU03427A (es) | ||
UY35748A (es) | Terapia combinada con laquinimod para el tratamiento de la esclerosis múltiple |